The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.

Sphere Bio's Cyto-Cellect Assay Kit integrates viability and antibody detection, streamlining workflows and ensuring optimal selection of high-producing clones.

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it ...

Terrain Minerals has hauled up some remarkable rare earths samples from its Lort River project near Esperance in Western ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

Urcosimod stable in single-use ampoules for more than 21⁄2 years FDA requires drug to show long-term shelf stability for approval Daily administration to patients via ampoules can minimize risk of ...

It is heartening that in a significant development in the fight against cancer, researchers have discovered peptides which ...

MAX RESOURCE CORP. (TSXV: MAX) (OTC Pink: MXROF) (FSE: M1D2) ("Max" or the "Company") is pleased to report an update on the ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

STONY BROOK, NY / ACCESS Newswire / March 26, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), ...